Ginkgo Bioworks Holdings, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 27.89 million compared to USD 34.1 million a year ago. Revenue was USD 37.94 million compared to USD 80.7 million a year ago.

Net loss was USD 165.91 million compared to USD 204.97 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.11 a year ago.